Skip to content
Home/GPs/ZEISS Ventures
DetailCard
ZEISS Ventures

ZEISS Ventures

Oberkochen, Germany·Founded 2019··zeiss.com

ZEISS Ventures is the corporate venture capital arm of the ZEISS Group, headquartered in Oberkochen, Germany. It is a strategic deep-tech investor targeting pre-Series A and Series A start-ups in Industrial Tech, MedTech and Life Sciences, writing initial tickets of EUR 0.5-5 million from an evergreen balance-sheet-funded programme. The team focuses on technology-driven ventures combining software and hardware with scalable global B2B business models, primarily across Europe and North America.

AUM
€140M
Funds
1
vintages 2019
Portfolio
13
Exits
3

ZEISS Ventures is an Oberkochen venture capital firm with €140M AUM, 13 active companies and 3 exits.

Key takeaways
  • ·3 exits in the last 5 years · consistent DPI cadence.
  • ·Average hold across 3 realized deals: 7 years.
  • ·Top sector focus: MedTech (44% of portfolio).

Sector breakdown

16 companies
MedTech
7 · 44%
Deep Tech
5 · 31%
Biotech
2 · 13%
HealthTech
1 · 6%
Consumer
1 · 6%

Geography breakdown

6 geographies
Germany
6 · 38%
Switzerland
4 · 25%
UK
2 · 13%
Finland
2 · 13%
US
1 · 6%
Norway
1 · 6%

Key facts

HQOberkochen, Germany
Founded2019
Employees22+
Websitezeiss.com

Recent exits

Scantinel Photonics

ZEISS Ventures sold Scantinel Photonics to MicroVision in 2025 after 4 years.

ZEISS Ventures sold Bridger Photonics to Beaverhead Partners LLC in 2022 after 4 years.

ZEISS Ventures sold Nanoscribe to CELLINK (BICO Group) in 2021 after 13 years.

Coverage notes

1 fund tracked, 16 portfolio companies (13 active · 3 realized). Verified weekly from public filings and deal announcements.

Funds & portfolio

Every fund ZEISS Ventures has raised, with its portfolio companies. Hand-checked from public filings.

1 fund
ZEISS Ventures CVCActive
Evergreen2019€140M13 assets3 exits

Unrealized

13 held
CompanyEntry
arcoris bio
Biotech · Switzerland
2025
Creal
Deep Tech · Switzerland
2024
Custom Surgical
MedTech · Germany
2026
Hypervision Surgical
MedTech · UK
2023
InSphero
Biotech · Switzerland
2023
Lidrotec
Deep Tech · Germany
2025
Maculaser
MedTech · Finland
2026
Mindpeak
HealthTech · Germany
2024
Morrow
Consumer · Norway
2022
Odne
MedTech · Switzerland
2025
Surgify Medical
MedTech · Finland
2025
Vibrosonic
MedTech · Germany
2023
ZOMP
MedTech · UK
2023

Realized

3 exits
CompanyEntryExitTypeBuyerMOIC
Bridger Photonics
Deep Tech · US
20182022Trade SaleBeaverhead Partners LLC–
Nanoscribe
Deep Tech · Germany
20082021Trade SaleCELLINK (BICO Group)–
Scantinel Photonics
Deep Tech · Germany
20212025Trade SaleMicroVision–

Frequently asked questions

What investment strategy does ZEISS Ventures focus on?
ZEISS Ventures focuses on VC, Growth strategies in the private equity space.
How many portfolio companies does ZEISS Ventures have?
ZEISS Ventures has 13 active portfolio companies and 3 completed exits and 1 fund tracked on GP Intel.
Where is ZEISS Ventures headquartered?
ZEISS Ventures is headquartered in Oberkochen, Germany.
What is ZEISS Ventures's assets under management?
ZEISS Ventures manages approximately €140M in assets under management.
When was ZEISS Ventures founded?
ZEISS Ventures was founded in 2019.
What sectors does ZEISS Ventures invest in?
ZEISS Ventures invests across Healthcare, Industrials, TMT.
What are ZEISS Ventures's recent exits?
Recent realized exits by ZEISS Ventures include: Scantinel Photonics (2025) to MicroVision; Bridger Photonics (2022) to Beaverhead Partners LLC; Nanoscribe (2021) to CELLINK (BICO Group).
Look up another firm or company
Last updated July 2026 · Sourced from public filings · Report an issue